newsfilter
← Latest News
PR Newswire·

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to...